← Back to Search

DOT mobile app for HIV (Human Immunodeficiency Virus)

N/A
Waitlist Available
Research Sponsored by Environment and Health Group, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Inclusion Criteria: (self report) Individuals who self-identify as a male, age 18-35, who has sex with men or who self-identify as a bisexual male or a gay male; currently taking PrEP; own a smartphone and desirous of adherence support.
-
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days
Awards & highlights

Study Summary

This study is evaluating whether a mobile health intervention can help improve adherence to the daily PrEP pill among culturally-diverse young adult men who have sex with men.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Wilson Self-reported Medication Adherence Scale
Secondary outcome measures
Intention to Follow PrEP Treatment Guidelines
Perceived Stress Scale
PrEP Medication Adherence Self Efficacy Scale
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Participants in the intervention arm will receive a mobile app to support their daily PrEP adherence.
Group II: ControlActive Control1 Intervention
Participants in the control group will receive a 2-page PrEP patient education document based information about PrEP from on the CDC website.

Find a Location

Who is running the clinical trial?

Environment and Health Group, Inc.Lead Sponsor
7 Previous Clinical Trials
731 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Mhealth for PrEP Adherence by Young Adult MSM, Phase 2
Patricia Weitzman 2021. "Mhealth for PrEP Adherence by Young Adult MSM, Phase 2". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04633200.
~26 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top